In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.
It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...
Rights Nov 19, 2007 Nov 26, 2007 Feb 12, 2007 Rights ratio: 1 share for every 1 held at a price of Rs 250.0 Bonus Nov 29, 2004 Nov 30, 2004 Jun 07, 2004 Bonus Ratio: 2 share(s) for every 1 shares held ...